The Second Affiliated Hospital, Zhejiang University School of Medicine — Hangzhou, Zhejiang

Public research footprint of The Second Affiliated Hospital, Zhejiang University School of Medicine, compiled from the ClinicalTrials.gov public registry.

293

Registered studies

170

Active

113

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Relapsed/Refractory Follicular Lymphoma · Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung… · Locally Advanced Unresectable or Metastatic Solid Tumors · Relapsed/Refractory Multiple Myeloma

Recently updated registry entries

NCT06624670 — A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma… (Recruiting)
NCT07741383 — A Study on the Efficacy and Safety of TEER Combined With Electrical Cardioversion in… (Recruiting)
NCT03886246 — Effisayil™ ON: A Study to Test Long-term Treatment With Spesolimab in People With… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at The Second Affiliated Hospital, Zhejiang University School of Medicine?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.